NOV:ETR
Novo Nordisk A/S
34,68 €
arrow_upward
+0,68%(+0,24) 1D
13. lis, 11:42:11 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NOV...
Otvori
34,72 €
Najviša
34,77 €
Najniža
34,60 €
Trž. kap.
129,60 mlr.
Prosj. kol.
180,74 tis.
Količina
32,83 tis.
52-tjed. najviša
54,87 €
52-tjed. najniža
30,24 €
Broj djelatnika
67 tis.
Otvori
34,72 €
Najviša
34,77 €
Najniža
34,60 €
Trž. kap.
129,60 mlr.
Prosj. kol.
180,74 tis.
Količina
32,83 tis.
52-tjed. najviša
54,87 €
52-tjed. najniža
30,24 €
Broj djelatnika
67 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 1 sat
BMO cuts Novo Nordisk stock target from USD 47.00 to USD 40.00
Yahoo Finance
·
prije 18 sati
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Investing.com India
·
prije 19 sati
BMO cuts Novo Nordisk stock price target on Ozempic headwinds By Investing.com
Foreign Policy Journal
·
prije 19 sati
Novo Nordisk (NYSE: NVO) Repurchases Over 23 Million B Shares Under DKK 15 Billion Buyback Programme
Profil
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk A/S – informacije
Glavni izvršni direktorMaziar Mike Doustdar
Zaposlenici66,7 tis.
Osnovano1923
SjedišteBagsværd, Hovedstaden, Danska
Sektor-
Web-lokacijanovonordisk.com